Examination of Phosphoprotein Targets in Timed Samples from Patients with RAS-Mutated AML during Concurrent Treatment with Alpelisib and Binimetinib on the Phase Ib Clinical Trial CMEK162X2109

BLOOD

AMER SOC HEMATOLOGY

1. Novartis
2. Celgene
3. Seattle Genetics